# Siemens Healthineers invests $300M in Walpole lab diagnostics plant

Siemens Healthineers will invest $300 million over four years to expand its lab diagnostics manufacturing facility in Walpole, Massachusetts, creating up to 700 new jobs. The site will produce reagents for the Atellica next-generation lab system.

- Type: Expansion
- Announced: 2017-02-01
- Where: Walpole, Massachusetts, United States
- Value: $300.0M
- Jobs: 700
- Status: announced
- Products: lab diagnostics reagents, Atellica lab system
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Siemens Healthineers](https://endata.com/companies/19309.md)

## Sources

- [devicemed.de](https://www.devicemed.de/siemens-healthineers-investiert-erheblich-in-fertigungsstaette-fuer-labordiagnostik-in-den-usa-a-577829/), 2017-02-01: "Die Erweiterung des Standorts Walpole fügt sich in die strategischen Wachstumspläne des Unternehmens ein und ermöglicht es uns, unsere Fertigungspräsenz im größten Markt des Gesundheitswesens weltweit zu verstärken."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.